Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Departments of Obstetrics and Gynecology, and Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
J Ovarian Res. 2023 Apr 12;16(1):74. doi: 10.1186/s13048-023-01141-1.
Polycystic ovarian syndrome (PCOS) is a complex multi-factorial syndrome associated with androgen excess and anovulatory infertility. In the current study, we investigated the role of dihydrotestosterone-induced exosomal miR-379-5p release in determining the destiny of the developing follicles. Our hypothesis was that androgen regulates granulosa cell miR-379-5p content by facilitating its exosomal release in a follicular-stage dependent manner, a process which determines granulosa cell fate. Compared to human non-PCOS subjects, individuals with PCOS exhibit higher follicular fluid free testosterone levels, lower exosomal miR-379-5p content and granulosa cell proliferation. Androgenized rats exhibited lower granulosa cell miR-379-5p but higher phosphoinositide-dependent kinase-1 (PDK1; a miR-379-5p target) content and proliferation. Androgen reduced granulosa cell miR-379-5p content by increasing its exosomal release in preantral follicles, but not in antral follicles in vitro. Studies with an exosomal release inhibitor confirmed that androgen-induced exosomal miR-379-5p release decreased granulosa cell miR-379-5p content and proliferation. Ovarian overexpression of miR-379-5p suppressed granulosa cell proliferation, and basal and androgen-induced preantral follicle growth in vivo. These findings suggest that increased exosomal miR-379-5p release in granulosa cells is a proliferative response to androgenic stimulation specific for the preantral stage of follicle development and that dysregulation of this response at the antral stage is associated with follicular growth arrest, as observed in human PCOS.
多囊卵巢综合征(PCOS)是一种与雄激素过多和排卵障碍性不孕相关的复杂多因素综合征。在本研究中,我们研究了二氢睾酮诱导的外泌体 miR-379-5p 释放在决定发育卵泡命运中的作用。我们的假设是,雄激素通过促进卵泡期依赖性的外泌体释放来调节颗粒细胞 miR-379-5p 的含量,这一过程决定了颗粒细胞的命运。与非 PCOS 个体相比,PCOS 个体的卵泡液游离睾酮水平更高,外泌体 miR-379-5p 含量和颗粒细胞增殖水平更低。雄激素化大鼠表现出较低的颗粒细胞 miR-379-5p,但较高的磷酸肌醇依赖性激酶-1(PDK1;miR-379-5p 的靶标)含量和增殖。雄激素通过增加颗粒细胞中 preantral 卵泡的外泌体释放来降低 miR-379-5p 的含量,但在体外的 antral 卵泡中则不会。外泌体释放抑制剂的研究证实,雄激素诱导的外泌体 miR-379-5p 释放减少了颗粒细胞 miR-379-5p 的含量和增殖。卵巢过表达 miR-379-5p 抑制了颗粒细胞的增殖,以及体内基础和雄激素诱导的 preantral 卵泡的生长。这些发现表明,颗粒细胞中外泌体 miR-379-5p 的释放增加是对卵泡发育的 preantral 阶段雄激素刺激的增殖反应,而在 antral 阶段这种反应的失调与卵泡生长停滞有关,正如在人类 PCOS 中观察到的那样。